These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17614103)

  • 1. Distinct patterns of motor nerve terminal sprouting induced by ciliary neurotrophic factor vs. botulinum toxin.
    Wright MC; Cho WJ; Son YJ
    J Comp Neurol; 2007 Sep; 504(1):1-16. PubMed ID: 17614103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciliary neurotrophic factor is not required for terminal sprouting and compensatory reinnervation of neuromuscular synapses: re-evaluation of CNTF null mice.
    Wright MC; Son YJ
    Exp Neurol; 2007 Jun; 205(2):437-48. PubMed ID: 17445802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciliary neurotrophic factor is required for motoneuron sprouting.
    Siegel SG; Patton B; English AW
    Exp Neurol; 2000 Dec; 166(2):205-12. PubMed ID: 11085886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle.
    Juzans P; Comella JX; Molgo J; Faille L; Angaut-Petit D
    Neuromuscul Disord; 1996 May; 6(3):177-85. PubMed ID: 8784806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin.
    Diaz J; Molgó J; Pécot-Dechavassine M
    Neurosci Lett; 1989 Jan; 96(2):127-32. PubMed ID: 2784552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic injections of ciliary neurotrophic factor induce sprouting by adult motor neurons.
    Kwon YW; Gurney ME
    Neuroreport; 1994 Mar; 5(7):789-92. PubMed ID: 8018851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological effects of ciliary neurotrophic factor treatment during neuromuscular synapse elimination.
    Jordan CL
    J Neurobiol; 1996 Sep; 31(1):29-40. PubMed ID: 9120434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular nerve sprouting induced by CNTF is associated with increases in CGRP content in mouse motor nerve terminals.
    Tarabal O; Calderó J; Esquerda JE
    Neurosci Lett; 1996 Nov; 219(1):60-4. PubMed ID: 8961304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
    Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological differences along mammalian motor nerve terminals for spontaneous and alpha-bungarotoxin-induced sprouting.
    Tomas J; Lanuza MA; Santafé M; Fenoll-Brunet MR; Garcia N
    Histol Histopathol; 2000 Jan; 15(1):43-52. PubMed ID: 10668194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions.
    Comella JX; Molgo J; Faille L
    Neurosci Lett; 1993 Apr; 153(1):61-4. PubMed ID: 8390032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of adhesive macromolecules with terminal sprouts at the neuromuscular junction after botulinum treatment.
    Lee RE; Tartell PB; Karmody CS; Hunter DD
    Otolaryngol Head Neck Surg; 1999 Feb; 120(2):255-61. PubMed ID: 9949361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin.
    Meunier FA; Colasante C; Faille L; Gastard M; Molgó J
    Pflugers Arch; 1996; 431(6 Suppl 2):R297-8. PubMed ID: 8739382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.
    Wright MC; Potluri S; Wang X; Dentcheva E; Gautam D; Tessler A; Wess J; Rich MM; Son YJ
    J Neurosci; 2009 Nov; 29(47):14942-55. PubMed ID: 19940190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyclonal antibodies against NCAM reduce paralysis-induced axonal sprouting.
    Schäfer R; Wernig A
    J Neurocytol; 1998 Aug; 27(8):615-24. PubMed ID: 10405028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A.
    Rogozhin AA; Pang KK; Bukharaeva E; Young C; Slater CR
    J Physiol; 2008 Jul; 586(13):3163-82. PubMed ID: 18467364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged paralysis, caused by the local injection of botulinum toxin, fails to cause motor nerve terminal sprouting in skeletal muscle of the frog.
    Antony MT; Sayers H; Stolkin C; Tonge DA
    Q J Exp Physiol; 1981 Oct; 66(4):525-32. PubMed ID: 6975950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells.
    Son YJ; Thompson WJ
    Neuron; 1995 Jan; 14(1):133-41. PubMed ID: 7826631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy.
    Simon CM; Jablonka S; Ruiz R; Tabares L; Sendtner M
    Hum Mol Genet; 2010 Mar; 19(6):973-86. PubMed ID: 20022887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor nerve outgrowth: reduced capacity for sprouting in the terminals of longer axons.
    Pestronk A; Drachman DB
    Brain Res; 1988 Nov; 463(2):218-22. PubMed ID: 3196914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.